Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Aerovance, Inc.
Chris Boshoff, Pfizer Oncology chief development officer, said lessons from the rapid pace of the company’s COVID-19 vaccine program are being applied to elranatamab and other cancer therapies.
The current coronavirus vaccines focus on the spike protein but the UK's Scancell believes it has a candidate that also targets the SARS-CoV-2 nucleocapsid protein which could help tackle existing and future variants.
Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.
Three requests for the accelerated assessment of planned EU marketing applications were considered by the European Medicines Agency last month.
- Large Molecule